GL1X · GenesisL1 explorer

MolNFT v1 · #122535 · protein

Discovery and pharmacological characterization of novel quinazoline- based PI3K delta-selective inhibitors

5IS5 · Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic…: “Discovery and pharmacological characterization of novel quinazoline- based PI3K delta-selective inhibitors”. X-ray diffraction, 1 ligand (6CY), 9 pockets (best druggability…

PDB
5IS5
Type
protein
Length
785 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
EC
2.7.1.153
UniProt
Q3UDT3
Ligands
6CY
Pockets
9 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 47% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (EC 2.7.1.153)protein78547% helix, 17% strandQ3UDT3

Ligands and binding sites

  • 6CY · 5-{4-[3-(4-acetylpiperazine-1-carbonyl)phenyl]quinazolin-6-yl}-2-methoxypyridine-3-carbonitrile · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111660.780.8083empty
25920.760.8295empty
37520.720.7887empty
42790.620.79466CY
51350.560.8220empty

Compared structures

  • 5IS5 · Discovery and Pharmacological Characterization of Novel Quinazoline-based PI3K… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.